| Identification | Back Directory | [Name]
Cyclobutanecarboxylic acid, 3-[2-[4-(8-chloro-4-oxo-4H-1-benzopyran-2-yl)phenoxy]ethoxy]-, ethyl ester | [CAS]
2413192-50-2 | [Synonyms]
HBV-IN-15
Cyclobutanecarboxylic acid, 3-[2-[4-(8-chloro-4-oxo-4H-1-benzopyran-2-yl)phenoxy]ethoxy]-, ethyl ester | [Molecular Formula]
C24H23ClO6 | [MOL File]
2413192-50-2.mol | [Molecular Weight]
442.89 |
| Hazard Information | Back Directory | [Uses]
HBV-IN-15 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-15 is a flavone derivative. HBV-IN-16 has the potential for the research of HBV infection (extracted from patent WO2020052774A1, compound 2)[1]. | [References]
[1] Dongdong Chen, et al. Flavone derivatives for the treatment and prophylaxis of hepatitis b virus disease. Patent WO2020052774A1. |
|
|